Quantification of inflammation in inflammatory eye diseases

Authors

  • Padmamalini Mahendradas Narayana Nethralaya, Super Speciality Eye Hospital and Postgraduate Institute of Ophthalmology, Bangalore
  • Anjani Khanna
  • Ankush Kawali
  • Rohit Shetty

DOI:

https://doi.org/10.15305/ijrci/v2iS1/102

Abstract

Measuring the cells and flare present in the anterior chamber and vitreous humor is a universally accepted method for quantifying inflammation in inflammatory eye diseases. However, one of the major disadvantages of this method is subjective grading. This can be overcome by measuring the cells and flare by laser flaremetry. But it is not widely available. The current review highlights the different methods and various parameters used clinically to assess the inflammation and the role of various imaging techniques in the diagnosis and monitoring of the response to treatment in ocular inflammatory diseases.

References

Brown Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature (SUN) for reporting clinical data.-Results of the First International Workshop. Am J Ophthalmol. 2005;150:509–16.

Nussenblatt RB, Palestine AG, Chan C, Roberge F. Standardization of vitreal inflammatory activityin intermediate and posterior uveitis. Ophthalmology. 1985; 92:467–471.

McCluskey PJ, Wakefield D. Prediction of response to treatment in patients with scleritis using a standardized scoring system. Aust N Z J Ophthalmology. 1991; 19:211–215.

NidaSen H, Sangave A, Goldstein DA, et al. A standardized grading system for scleritis. Ophthalmology. Apr 2011; 118(4): 768–771.

Ni M, Bloom JN, Lele S, Sotelo-Avila C. A laboratory evaluation of the Kowa laser flare-cell meter for the study of uveitis. Graefes Arch ClinExpOphthalmol. 1992;230:547–51.

Gonzales CA, Ladas JG, Davis JL, Feuer WJ, Holland GN. Relationships between laser flare photometry values and complications of uveitis. Arch. Ophthalmol.2001:119(12); 1763–69.

Sawa M, Tsurimaki Y, Tsuru T, Shimizu H. New quantitative method to determine protein concentration and cell number in aqueous in vivo . Jpn. J. Ophthalmol.1988: 32(2);132–42.

Onodera T, Gimbel HV, DeBroff BM. Aqueous flare and cell number in healthy eyes of Caucasians. Jpn. J. Ophthalmol.1993: 37(4);445–51.

Guillén-Monterrubío OM, Hartikainen J, Taskinen K, Saari KM. Quantitative determination of aqueous flare and cells in healthy eyes. ActaOphthalmol Scand.1997:75(1);58–62.

Herbort CP, Guex-Crosier Y, de Ancos E, Pittet N. Use of laser flare photometry to assess and monitor inflammation in uveitis. Ophthalmology 1997:104(1);64–71.

Tugal-Tutkun I, Cingü K, Kir N, Yeniad B, Urgancioglu M, Güln A. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis.Graefes Arch. Clin. Exp. Ophthalmol.2008: 246(8);1169–77.

Yang P, Fang W, Huang X, Zhou H, Wang L, Jiang B. Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet’s disease. Int. Ophthalmol.2010: 30(5);485–89.

Küchle M, Nguyen NX. Analysis of the blood–aqueous barrier by measurement of aqueous flare in 31 eyes with Fuchs’ heterochromic uveitis with and without secondary open-angle glaucoma. Klin. Monbl. Augenheilkd.2000: 217(3);159–62.

Yang P, Fang W, Jin H, Li B, Chen X, Kijlstra A. Clinical features of Chinese patients with Fuchs’ syndrome. Ophthalmology 2006: 113(3); 473–80.

Tugal-Tutkun I, Güney-Tefekli E, Kamaci-Duman F, Corum I. A cross-sectional and longitudinal study of Fuchs uveitis syndrome in Turkish patients. Am.Ophthalmol.2009:148(4); 510-15.

Bouchenaki N, Herbort CP. Fluorescein angiographic findings and clinical features in Fuchs’ uveitis. Int. Ophthalmol.2010: 30(5); 511–519.

Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am. J. Ophthalmol.2007: 143(4);647–655.

Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am. J.Ophthalmol.2007: 143(5); 840–846.

Piccolino CF, Grosso A, Savini E. Fundus autofluorescence in serpiginous choroiditis Graefes Arch Clin Exp Ophthalmol (2009) 247:179–185.

Gupta A, Bansal R, Gupta V, Sharma A. Fundus autofluorescence in serpiginous like choroiditis. Retina. 2012;32:814–25.

Vasconcelos-Santos DV, Sohn E H, Sadda S, RaoN.A. Retinal pigment epithelial changes in chronic Vogt-Koyanagi-Harada disease: fundus autofluorescence and spectral domainoptical coherence tomography findings.Retina. 2010 January; 30(1): 33–41.

Miyake K. Prevention of cystoid macular oedema after lens extraction by topical indomethacin: a preliminary report. Graefes Arch KlinExpOphthalmol 1977;203:81–8.

Yannuzzi LA. A perspective on the treatment of aphakiccystoidmacular edema. SurvOphthalmol 1984;28:540–53.

Kempen JH, Sugar EA, Jaffe GJ, et al. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology 2013;120:1852–9.

Mahendradas P, Madhu S, Kawali A, et al. Combined depth imaging of choroid in uveitis. Journal of Ophthalmic Inflammation and Infection 2014, 4:18.

Phoebe Lin, Eric B. SuhlerandJames T. Rosenbaum. The Future of Uveitis Treatment.Ophthalmology. 2014 January ; 121(1): 365–376.

Yoshimura T, Sonoda KH, Ohguro N, et al. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford). 2009; 48(4):347–54.

Takase H, Futagami Y, Yoshida T, et al. Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1557-61.

Curnow SJ, Falciani F, Durrani OM, et al. Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis.Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4251-9.

Downloads

Published

30-12-2014